Silo Pharma Subsidiary QwikAgents Accepted into AMD AI Developer Program

Silo Pharma (NASDAQ: SILO) announced that its wholly owned subsidiary, QwikAgents, has been accepted into Advanced Micro Devices’ AMD AI Developer Program. The program provides QwikAgents with access to AMD Developer Cloud credits, AI development tools, training resources, and a global developer community. According to the company, this initiative is expected to accelerate the development, testing, optimization, and deployment of its AI agent platform across consumer and enterprise applications.

QwikAgents is developing a platform that enables users to deploy persistent AI agents for tasks including research, content generation, scheduling, coding, and workflow automation. The platform aims to serve individuals, developers, small businesses, and enterprise customers. Silo Pharma stated that participation in the AMD AI Developer Program is expected to support platform performance, agent reliability, and scalable deployment as QwikAgents expands its capabilities.

For more details, the full press release is available at https://ibn.fm/313SC.

Silo Pharma is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company. Its therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The company’s portfolio includes innovative programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Silo’s research is conducted in collaboration with leading universities and laboratories. More information is available at silopharma.com.

This development underscores Silo Pharma’s strategic diversification into AI technology through its QwikAgents subsidiary. By leveraging AMD’s AI ecosystem, QwikAgents aims to enhance its platform’s performance and scalability, potentially positioning it as a competitive player in the AI agent market. The acceptance into the AMD AI Developer Program could also provide QwikAgents with valuable resources and community support to accelerate product development and market readiness.

Investors and stakeholders can find the latest news and updates relating to SILO in the company’s newsroom at https://ibn.fm/SILO.